We invest in companies that have potential breakthrough treatments with promising data and a reasonable Proof of Concept of efficacy and safety.
We invest in medical device companies developing novel products and technologies with the potential to change the landscape in their areas.
We may also selectively make investments in companies with technologies that have the potential for an impact on helping the environment.
Our proprietary approach is based on sourcing of novel opportunities with the potential to be breakthroughs in their own areas, structuring investment on a case by case basis, supporting the portfolio companies and facilitating corporate deals. We invest primarily in the life sciences (Pharma, Biotech, MedTech) with a particular focus on safe and efficacious treatments for serious diseases.
We are devoted to addressing unmet medical needs through financing the development of novel products and technologies that can help alleviate human suffering from disease, while supporting the environment.